Exogenous control of mammalian gene expression through modulation of RNA self-cleavage
暂无分享,去创建一个
R. D'Amato | R. Mulligan | Laising Yen | Jennifer Svendsen | Jeng-Shin Lee | J. Gray | M. Magnier | Takashi Baba
[1] A. Aszalos,et al. Identification of antibiotic 1037 as toyocamycin. , 1966, The Journal of antibiotics.
[2] G D Stormo,et al. Sequence requirements of the hammerhead RNA self-cleavage reaction. , 1990, Biochemistry.
[3] T. Cech. Self-Splicing and Enzymatic Activity of an Intervening Sequence RNA from Tetrahymena , 1990, Bioscience reports.
[4] Self‐Splicing and Enzymatic Activity of an Intervening Sequence RNA from Tetrahymena , 1990 .
[5] T. Braun,et al. The muscle regulatory gene, Myf-6, has a biphasic pattern of expression during early mouse development , 1991, The Journal of cell biology.
[6] J. Davies,et al. Antibiotic inhibition of group I ribozyme function , 1991, Nature.
[7] M. Gossen,et al. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[8] R Cedergren,et al. Numbering system for the hammerhead. , 1992, Nucleic acids research.
[9] M. Rudnicki,et al. Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death , 1992, Cell.
[10] I. Nonaka,et al. Myogenin gene disruption results in perinatal lethality because of severe muscle defect , 1993, Nature.
[11] M. Rudnicki,et al. MyoD or Myf-5 is required for the formation of skeletal muscle , 1993, Cell.
[12] Y Wang,et al. A regulatory system for use in gene transfer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Mcswiggen,et al. In vitro and in vivo comparison of hammerhead, hairpin, and hepatitis delta virus self-processing ribozyme cassettes. , 1994, The Journal of biological chemistry.
[14] S. Tajbakhsh,et al. Lineage restriction of the myogenic conversion factor myf-5 in the brain. , 1995, Development.
[15] O. Uhlenbeck,et al. Inhibition of the hammerhead ribozyme by neomycin. , 1969, RNA.
[16] T. Ley,et al. Long-range disruption of gene expression by a selectable marker cassette. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[17] B. Wold,et al. Know Your Neighbors: Three Phenotypes in Null Mutants of the Myogenic bHLH Gene MRF4 , 1996, Cell.
[18] Shannon R. Magari,et al. A humanized system for pharmacologic control of gene expression , 1996, Nature Medicine.
[19] R. Mulligan,et al. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[20] S. Tajbakhsh,et al. Muscle progenitor cells failing to respond to positional cues adopt non-myogenic fates in myf-5 null mice , 1996, Nature.
[21] Antibiotic interactions with the hammerhead ribozyme:tetracyclines as a new class of hammerhead inhibitor. , 1996, The Biochemical journal.
[22] R. Jaenisch,et al. Myogenin can substitute for Myf5 in promoting myogenesis but less efficiently. , 1997, Development.
[23] G. Cossu,et al. Redefining the Genetic Hierarchies Controlling Skeletal Myogenesis: Pax-3 and Myf-5 Act Upstream of MyoD , 1997, Cell.
[24] M. Zillmann,et al. In vitro optimization of truncated stem-loop II variants of the hammerhead ribozyme for cleavage in low concentrations of magnesium under non-turnover conditions. , 1997, RNA.
[25] M. Rudnicki,et al. MyoD and Myf-5 differentially regulate the development of limb versus trunk skeletal muscle. , 1997, Development.
[26] S. Koester,et al. Ectopic Pax-3 Activates MyoD and Myf-5 Expression in Embryonic Mesoderm and Neural Tissue , 1997, Cell.
[27] E. Westhof,et al. Deciphering RNA recognition: aminoglycoside binding to the hammerhead ribozyme. , 1998, Chemistry & biology.
[28] David K. Stevenson,et al. Bioluminescent indicators in living mammals , 1998, Nature Medicine.
[29] F. Gage,et al. High level transactivation by a modified Bombyx ecdysone receptor in mammalian cells without exogenous retinoid X receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[30] Wei Zhang,et al. Overlapping functions of the myogenic bHLH genes MRF4 and MyoD revealed in double mutant mice. , 1998, Development.
[31] E. Westhof,et al. Aminoglycoside binding to the hammerhead ribozyme: a general model for the interaction of cationic antibiotics with RNA. , 1998, Journal of molecular biology.
[32] P. Baldacci,et al. Nonpermissiveness for mouse embryonic stem (ES) cell derivation circumvented by a single backcross to 129/Sv strain: establishment of ES cell lines bearing the Omd conditional lethal mutation , 1998, Mammalian Genome.
[33] Robert Cedergren,et al. Schistosome Satellite DNA Encodes Active Hammerhead Ribozymes , 1998, Molecular and Cellular Biology.
[34] J. Szostak,et al. In vitro selection of functional nucleic acids. , 1999, Annual review of biochemistry.
[35] M. Rudnicki,et al. Myogenic determination occurs independently in somites and limb buds. , 1999, Developmental biology.
[36] T. Lockett,et al. Selected classes of minimised hammerhead ribozyme have very high cleavage rates at low Mg2+ concentration. , 1999, Nucleic acids research.
[37] J. Moran,et al. Limbs move beyond the Radical fringe , 1999, Nature.
[38] R Cedergren,et al. Hammerhead-mediated processing of satellite pDo500 family transcripts from Dolichopoda cave crickets. , 2000, Nucleic acids research.
[39] Philippe Soriano,et al. Early myotome specification regulates PDGFA expression and axial skeleton development. , 2000, Development.
[40] S. Tajbakhsh,et al. The birth of muscle progenitor cells in the mouse: spatiotemporal considerations. , 2000, Current topics in developmental biology.
[41] T. Braun,et al. Myf-5 Revisited Loss of Early Myotome Formation Does Not Lead to a Rib Phenotype in Homozygous Myf-5 Mutant Mice , 2000, Cell.
[42] S. Tapscott,et al. Molecular Distinction between Specification and Differentiation in the Myogenic Basic Helix-Loop-Helix Transcription Factor Family , 2001, Molecular and Cellular Biology.
[43] Rapid identification and characterization of hammerhead-ribozyme inhibitors using fluorescence-based technology , 2001, Nature Biotechnology.
[44] P. Morcos. Achieving efficient delivery of morpholino oligos in cultured cells , 2001, Genesis.
[45] P. Rigby,et al. A BAC transgenic analysis of the Mrf4/Myf5 locus reveals interdigitated elements that control activation and maintenance of gene expression during muscle development. , 2001, Development.
[46] Ronald R. Breaker,et al. Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression , 2002, Nature.
[47] R. Breaker. Engineered allosteric ribozymes as biosensor components. , 2002, Current opinion in biotechnology.
[48] P. Rigby,et al. Expression of the myogenic regulatory factor Mrf4 precedes or is contemporaneous with that of Myf5 in the somitic bud , 2002, Mechanisms of Development.
[49] David R Corey,et al. Novel antisense and peptide nucleic acid strategies for controlling gene expression. , 2002, Biochemistry.
[50] M. Rudnicki,et al. Myf5 and MyoD activation define independent myogenic compartments during embryonic development. , 2003, Developmental biology.
[51] S. Tajbakhsh. Stem cells to tissue: molecular, cellular and anatomical heterogeneity in skeletal muscle. , 2003, Current opinion in genetics & development.
[52] S. Silverman,et al. Rube Goldberg goes (ribo)nuclear? Molecular switches and sensors made from RNA. , 2003, RNA.
[53] R. Breaker,et al. Adenine riboswitches and gene activation by disruption of a transcription terminator , 2004, Nature Structural &Molecular Biology.
[54] R. Breaker,et al. Control of gene expression by a natural metabolite-responsive ribozyme , 2004, Nature.
[55] T. Cech. RNA finds a simpler way , 2004, Nature.
[56] V. Luria,et al. Maternally expressed PGK-Cre transgene as a tool for early and uniform activation of the Cre site-specific recombinase , 1998, Transgenic Research.